Benitec signs license deal with Calando
21 June, 2005 by Ruth BeranCalifornian biopharmaceutical company Calando Pharmaceuticals has granted an exclusive worldwide license to Benitec (ASX:BLT) for the use of its polymeric nucleic acid delivery technology, which Benitec will use in conjunction with its RNA interference (RNAi)-based therapeutic for hepatitis C virus (HCV).
The sheep genome project
16 June, 2005 by Graeme O'NeillAustralia and New Zealand research and funding agencies are joining hands across the Tasman for a major genomics project on the animal on which both nations' economies were founded -- the sheep.
Lab-on-a-chip shows analytical prowess
15 June, 2005 by Graeme O'NeillThe Australian Centre for Research on Separation Science (ACROSS) at the University of Tasmania has opened a new million-dollar laboratory to develop and manufacture microfluidics chips capable of analysing samples thousands of times smaller than a drop of water.
US group to fund Australian spinal cord map
10 June, 2005 by Susan WilliamsonResearchers at the Spinal Injuries Research Centre at the Prince of Wales Medical Research Institute have received AUD$200,000 from the Christopher Reeve Paralysis Foundation to produce a three-dimensional map of the rat spinal cord that will be made publicly available on the internet.
Billion dollar baby
25 May, 2005 by Staff WritersWhen Diana Hill went looking for significant new commercial opportunities in New Zealand's meat industry, she decided she'd better get down and dirty, so she spent a month in a meat processing plant asking where the hell the next billion dollar business was.
Feds to fund new human genetics advisory committee
13 May, 2005 by Ruth BeranThe federal government has used the budget to announce that it will provide AUD$7.6 million over four years to establish and fund the activities of a new human genetics advisory committee.
Dr Wells and the genetic crusade
12 May, 2005 by Graeme O'NeillA young American genetist is embarking on a project which could solve many of the mysteries of human history, and give each of us a chance to find out about our our oldest ancestors.
Biomarker laboratory to mine the proteome
04 May, 2005 by Renate KrelleA new Biomarker Discovery Laboratory was opened today at Australian Proteomics Analysis Facility (APAF) at Macquarie University, approximately ten years after scientists including Keith Williams and Marc Wilkins initiated the science now known as 'proteomics' on that very site.
Scientists search for Parkinsons genes in Tasmania
04 May, 2005 by Graeme O'NeillWithin a day of putting out a call for families with a history of Parkinson's disease to participate in a project to identify susceptibility genes for the disease, Hobart's Menzies Research Institute had five families signed up.
New Proteome boss talks of company in transition
29 April, 2005 by Renate KrelleNew Proteome Systems chief executive Stephen Porges (ASX:PXL) believes the company is caught in the middle of a typical biotech transformation from its original focus as a tools business to a diagnostics and therapeutics business -- which is where its real future lies.
Williams steps down as Proteome Systems' CEO
28 April, 2005 by Renate KrelleKeith Williams has stepped down from the helm of Proteome Systems (ASX:PXL), and the company has appointed strategic management specialist Stephen Porges as chief executive officer.
DNA markers to help track humans' movement across the globe
15 April, 2005 by Graeme O'NeillIn the nick of time -- in terms of human history, anyway -- the National Geographic Society and IBM have announced a five year project that will use DNA markers to retrace the epic colonisation of Earth by modern human beings.
NZ moves to extend controls on xenotransplantation
13 April, 2005 by Renate KrelleThe NZ government looks likely to extend strict controls on xenotransplantation until at least December 2006 after a bill requiring trials of the technology to be approved by the minister had its first reading in the NZ parliament yesterday.
Benitec and Alnylam swop RNAi licenses
13 April, 2005 by Staff WritersBrisbane company Benitec (ASX:BLT) has signed a reciprocal licensing agreement with one of its biggest competitors in the RNAi field, US company Alnylam Pharmaceuticals.
The mammalian genome and phenome
07 April, 2005 by Christopher GoodnowChris Goodnow talks about defining the mammalian phenome and how this may pan out in the future.
